Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1987-12-14
1991-07-02
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 51, 536 23, A61K 3170, C07H 1909
Patent
active
050285963
ABSTRACT:
The invention is a method for using 1-(.beta.-D-arabinofuranosyl)-5-propynyluracil or its salts as the active ingredient in pharmaceutical compositions in the treatment of varicella zoster viral infections whether expressed as chicken pox or shingles.
REFERENCES:
patent: 4247544 (1981-01-01), Bergstrom et al.
patent: 4267171 (1981-05-01), Bergstrom et al.
patent: 4863906 (1989-09-01), Rahim et al.
Martin et al., Journal of Pharmaceutical Science, vol. 56, No. 2, 1987, pp. 180-184.
E. De Clercq et al., Targets for the Design of Antiviral Agents, Jun. 19-Jul. 2, 1983, pp. 203-231-.COPYRGT., 1984.
De Clerk, E., "Synthetic Pyrimidine Nucleoside Analogs", in Approaches to Antiviral Agents, Harnden, Editor, (VCH Publisher: Deerfield Beach, Fla., 1985), pp. 57-99.
J. Med. Chem., 1983, 26(5), pp. 661-666.
J. Med. Chem, 1983, 26(9), pp. 1252-1257.
J. Med. Chem., 1984, 27(3), pp. 410-412.
Febs. Symp., 1979, 57, pp. 275-285.
Biochem Pharmacol., 1983, 32(4), pp. 726-729.
Nucleic Acids Symp. Ser., 1981, 9, pp. 103-106.
Antimicrobial Agents Chemother., 1980, 17(6), pp. 1030-1031.
Antiviral Research, 1981, 1(4), pp. 213-223.
Nucleosides and Nucleotides, 1986, 5(5), pp. 571-578.
Antiviral Research 4(3), pp. 159-168, 1984.
Int. Congr. Ser. Excerpta. Med. Herpes Virus Clin. Pharmacol. Basic Aspects, pp. 211-214, 1982.
Acta. Microbiol. Acad. Sci. Hung., 1981, 28(3), pp. 307-312.
Antiviral Chemother. Des. Inhib. Viral Function, 1981 Proc. Symp. Antiviral Chemotherap., pp. 207-217.
Antimicrob. Agents, 23(3), pp. 416-421, 1983.
Mol. Pharmacol., (1982), 21, pp. 217-223.
Nucleic. Acids Res. Spec., Pub. (1978), 4, pp. 103-106.
Purifoy Dorothy J. M.
Rahim Saad G.
Brown Donald
Brown Johnnie R.
Burroughs Wellcome Co.
Kunz Gary L.
Nielsen Lawrence A.
LandOfFree
1-(.beta.-D-arabinofuranosyl)-5-propynyluracil for treatment of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-(.beta.-D-arabinofuranosyl)-5-propynyluracil for treatment of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(.beta.-D-arabinofuranosyl)-5-propynyluracil for treatment of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1247284